Vulnerabilities

Vulnerability · CVE-2025-62264

Reflected cross-site scripting (XSS) vulnerability in Languauge Override in Liferay Portal 7.4.3.8 through 7.4.3.111, and Liferay DXP 2023.Q4.0 through 2023.Q4.10, 2023.Q3.1 throug

Published Oct 31, 2025 · catalog updated Oct 31, 2025 · Liferay DXP

Last checked Oct 25, 2026. A connected source was read within the last 7 days.

Check this week

CVE-2025-62264 is not in CISA KEV. FIRST estimates a 24.00% chance of exploitation in the next 30 days. Check whether you run Liferay DXP.

Gaps on this record

  • No vendor fix or required action is stored. Compare the linked advisory before you change production.

Same product and reporting

Severity
Medium5.1
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
24.00%
Remediation
Advisory link
Affected products
vendor Liferay DXP 7.4.13-u4 ≤7.4.13-u92

Reflected cross-site scripting (XSS) vulnerability in Languauge Override in Liferay Portal 7.4.3.8 through 7.4.3.111, and Liferay DXP 2023.Q4.0 through 2023.Q4.10, 2023.Q3.1 through 2023.Q3.10, and 7.4 update 4 through update 92 allows remote attackers to inject arbitrary web script or HTML via the parameter.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • vendor Liferay DXP 7.4.13-u4 ≤7.4.13-u927.4.13-u4 ≤7.4.13-u92

How to fix CVE-2025-62264

  • No stored fix

    No vendor fix text is stored. Use the linked advisory before you change production.

  • Version check

    Seen in 7.4.13-u4 ≤7.4.13-u92

  • Advisory

    Open the cve_org record and follow its fix.

  • Official advisories

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

CVE-2025-62264 is not in CISA KEV. FIRST estimates a 24.00% chance of exploitation in the next 30 days. Check whether you run Liferay DXP.

Which versions are affected?

Compare what you have installed with Liferay DXP 7.4.13-u4 ≤7.4.13-u92 7.4.13-u4 ≤7.4.13-u92. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

No weakness class is stored. EPSS 24.00%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. Oct 31, 2025 · EUVD

    Detected

    Reflected cross-site scripting (XSS) vulnerability in Languauge Override in Liferay Portal 7.4.3.8 through 7.4.3.111, and Liferay DXP 2023.Q4.0 through 2023.Q4.10, 2023.Q3.1 through 2023.Q3.10, and 7.4 update 4 through update 92 allows remote attackers to inject arbitrary web script or HTML via the parameter.

  2. Oct 31, 2025 · EUVD

    Updated

    Reflected cross-site scripting (XSS) vulnerability in Languauge Override in Liferay Portal 7.4.3.8 through 7.4.3.111, and Liferay DXP 2023.Q4.0 through 2023.Q4.10, 2023.Q3.1 through 2023.Q3.10, and 7.4 update 4 through update 92 allows remote attackers to inject arbitrary web script or HTML via the parameter.

Sources

  • CVE.orgVulnerability recordCVE-2025-62264

    Official CVE identifier

    cve.org
  • EUVDVulnerability recordEUVD-2025-37387

    Reflected cross-site scripting (XSS) vulnerability in Languauge Override in Liferay Portal 7.4.3.8 through 7.4.3.111, and Liferay DXP 2023.Q4.0 through 2023.Q4.10, 2023.Q3.1 through 2023.Q3.10, and 7.4 update 4 through update 92 allows remote attackers to inject arbitrary web scr

    euvd.enisa.europa.eu

References

Freshness

Last verified in this catalog Oct 31, 2025. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.

  • CVE.orgOct 25, 2026
  • EUVDOct 25, 2026